Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 11/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | SMO | Q99835 | 1/20 | 0.33 |
| ▸ | HCRTR1 | O43613 | 2/20 | 0.33 |
| ▸ | HCRTR2 | O43614 | 2/20 | 0.33 |
| ▸ | SMYD3 | Q9H7B4 | 2/20 | 0.32 |
| ▸ | CNR1 | P21554 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14450215 | 0.72 | ACACB (0.42) | KMT2A | |
| SCHEMBL3882887 | 0.70 | CA1 (0.36) | CNR2ALDH1A1KMT2ASMOSMYD3 | |
| SCHEMBL3882891 | 0.70 | CA1 (0.36) | CNR2ALDH1A1KMT2ASMOSMYD3 | |
| SCHEMBL12400788 | 0.70 | CA1 (0.36) | CNR2ALDH1A1KMT2ASMOSMYD3 | |
| SCHEMBL8252188 | 0.68 | ACACB (0.48) | KMT2A | |
| SCHEMBL28381329 | 0.67 | HDAC4 (0.45) | SMOSMYD3 | |
| SCHEMBL6370550 | 0.65 | HCRTR1 (0.43) | CNR2KMT2AHCRTR1HCRTR2SMYD3 | |
| SCHEMBL21679076 | 0.64 | MMP2 (0.38) | ALDH1A1KMT2ASMYD3 | |
| SCHEMBL1128579 | 0.64 | EPHX2 (0.42) | CNR2KMT2ASMOHCRTR1HCRTR2 | |
| SCHEMBL4355370 | 0.64 | EPHX2 (0.42) | CNR2KMT2ASMOHCRTR1HCRTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005040142-A9 | NOVEL KETO-OXADIAZOLE DERIVATIVES AS CATHEPSIN INHIBITORS | AVENTIS PHARMA INC (US) | 2005-06-09 | — | — | WO | disclosed |